Baseline Serum Interleukin-6 Levels Predict the Response of Patients with Advanced Non-small Cell Lung Cancer to PD-1/PD-L1 Inhibitors

Although various studies on predictive markers in the use of PD-1/PD-L1 inhibitors are in progress, only PD-L1 expression levels in tumor tissues are currently used. In the present study, we investigated whether baseline serum levels of IL-6 can predict the treatment response of patients with advanc...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Da Hyun, Park, Cheol-Kyu, Chung, Chaeuk, Oh, In-Jae, Kim, Young-Chul, Park, Dongil, Kim, Jinhyun, Kwon, Gye Cheol, Kwon, Insun, Sun, Pureum, Shin, Eui-Cheol, Lee, Jeong Eun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Immunologists 2020
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327149/
https://www.ncbi.nlm.nih.gov/pubmed/32655975
http://dx.doi.org/10.4110/in.2020.20.e27

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327149/
https://www.ncbi.nlm.nih.gov/pubmed/32655975
http://dx.doi.org/10.4110/in.2020.20.e27

Ejemplares similares